Author/Authors :
Hoseini، Bibi Leila نويسنده Midwifery MSc; Faculty Member of Midwhfery Department, Sabzevar University of Medical Sciences, Sabzevar, Iran. , , Ajilian Abbasi، Maryam نويسنده Ibn-e- Sina Hospital, Mashhad University of Medical Sciences, Mashhad, Iran. , , Taghizade Moghaddam، Habibolah نويسنده Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. , , Khademi، Gholamreza نويسنده Assistant Professor, Department of Pediatrics, Mashhad University of Medical Sciences, Mashhad, Iran. , , Saeidi، Masumeh نويسنده Students Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran Saeidi, Masumeh
Abstract :
Attention-deficit/hyperactivity disorder (ADHD) is a chronic condition that affects millions of children and often persists into adulthood. ADHD includes a combination of problems, such as difficulty sustaining attention, hyperactivity and impulsive behavior. ADHD is estimated to affect about 6 to 7 percent of people aged 18 and under when diagnosed via the DSM-IV criteria. Hyperkinetic disorder when diagnosed via the ICD-10 criteria give rates of between 1 to 2 percent in this age group. Children in North America appear to have a higher rate of ADHD than children in Africa and the Middle East; however, this may be due to differing methods of diagnosis used in different areas of the world. If the same diagnostic methods are used rates are more or less the same between countries. While treatment wonʹt cure ADHD, it can help a great deal with symptoms. Treatment typically involves medications and behavioral interventions. Early diagnosis and treatment can make a big difference in outcome.
